Vraylar 3 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FB9J4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,832
Award facts
- Contract value 100% obligated
- $26,832.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Vraylar 3 mg capsules (30-count packages) with a ceiling value of $26,832.04. This is a firm fixed-price delivery order with no set-aside designation, indicating the contract was competitively awarded. The order is scheduled for ultimate completion on April 25, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a $999,999,999.00 value through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive capability in supplying diverse pharmaceutical products across multiple therapeutic domains, including neurological treatments like Vraylar. As a prime vendor under the DLA Pharmaceutical Prime Vendor Global Program, AmerisourceBergen maintains the flexibility to fulfill medical supply needs for customers including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for Vraylar represents routine pharmaceutical supply fulfillment under the company's comprehensive contract vehicle with the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DB25FB9J4?
SPE2DB25FB9J4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 24, 2025.
How much is contract SPE2DB25FB9J4 worth?
The government has obligated $26,832 on SPE2DB25FB9J4.
Is contract SPE2DB25FB9J4 an order under another contract?
Yes. SPE2DB25FB9J4 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FB9J4 competed?
The extent of competition for SPE2DB25FB9J4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award